1. Lu, Xuan, Li, Ying, Yang, Yan, Chai, Xingxing, Gong, Chen. 2023. OLFML2A Overexpression Predicts an Unfavorable Prognosis in Patients with AML. In Journal of oncology, 2023, 6017852. doi:10.1155/2023/6017852. https://pubmed.ncbi.nlm.nih.gov/36873740/
2. Gao, Xiufei, Yang, Zimei, Xu, Chuchu, Wu, Chunyu, Chen, Mingcang. . GeneChip expression profiling identified OLFML2A as a potential therapeutic target in TNBC cells. In Annals of translational medicine, 10, 274. doi:10.21037/atm-22-757. https://pubmed.ncbi.nlm.nih.gov/35433966/
3. Sun, Xiao-Hong, Wan, Shun, Chai, Yi-Hong, Li, Hong-Xing, Xi, Ya-Ming. 2023. Identifying a prognostic model and screening of potential natural compounds for acute myeloid leukemia. In Translational cancer research, 12, 1535-1551. doi:10.21037/tcr-22-2500. https://pubmed.ncbi.nlm.nih.gov/37434693/
4. Hong, Eun Pyo, Youn, Dong Hyuk, Kim, Bong Jun, Jeon, Hong Jun, Jeon, Jin Pyeong. 2022. Fine-mapping of intracranial aneurysm susceptibility based on a genome-wide association study. In Scientific reports, 12, 2717. doi:10.1038/s41598-022-06755-x. https://pubmed.ncbi.nlm.nih.gov/35177760/
5. Pérez-Ibave, Diana Cristina, González-Alvarez, Rafael, de La Luz Martinez-Fierro, Margarita, Barrera-Saldaña, Hugo Alberto, Rodríguez-Sánchez, Irám Pablo. 2016. Olfactomedin-like 2 A and B (OLFML2A and OLFML2B) expression profile in primates (human and baboon). In Biological research, 49, 44. doi:. https://pubmed.ncbi.nlm.nih.gov/27821182/
6. AvŞar, Timuçin, ÇaliŞ, Şeyma, Yilmaz, Baran, Holyavkİn, Can, KiliÇ, Türker. 2020. Genome-wide identification of Chiari malformation type I associated candidate genes and chromosomal variations. In Turkish journal of biology = Turk biyoloji dergisi, 44, 449-456. doi:10.3906/biy-2009-19. https://pubmed.ncbi.nlm.nih.gov/33402871/
智鼠故事 
